President, US Pharmaceuticals, GlaxoSmithKline; MBA, Keenan Flagler School of Business, University of North Carolina
Jack Bailey oversees GSK’s pharmaceuticals and vaccines businesses in the US and Puerto Rico. In this role, Jack draws upon 25 years of industry experience and a successful track record of leading organizations through change, delivering strong business performance and maintaining a focus on patient access and affordability. Jack joined GSK in 2009 as senior vice president leading groups responsible for payers, public policy, and government affairs. Prior to joining GSK, Jack had a successful 18-year career with Eli Lilly, where he served in a variety of commercial leadership roles including senior vice president of the account-based markets division, general manager for South Africa, and area director for the sub-Saharan region. Jack lives in North Carolina with his wife and two children. He is actively involved with the NC Biotechnology Center, the NC Healthcare Quality Alliance, the NC Chamber of Commerce and the Health Policy and Management Executive Council at the Harvard T.H. Chan School of Public Health.
Session Synopsis: This panel promises an exciting discussion around the interplay between universities and entrepreneurship, the creation of intellectual property and building biotech. Different leaders across academia, venture capital, and companies will join this discussion of how to connect university activities and researchers with the emerging biotech sector for successful business development that can catapult the Research Triangle beyond Silicon Valley.